FBB
TECH icon

Fulton Breakefield Broenniman’s Bio-Techne TECH Stock Holding History

Fulton Breakefield Broenniman’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,435
Closed -$228K – 210
2025
Q2 		$228K Buy
4,435
+125
+3% +$6.28K 0.02% 176
2025
Q1 		$253K Buy
+4,310
New +$292K 0.02% 157

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Fulton Breakefield Broenniman's TECH Position: Q3 2025 in Review

Fulton Breakefield Broenniman sold out of Bio-Techne (TECH) in Q3 2025, closing a stake of 4,435 shares — an estimated $228K sold.

Fulton Breakefield Broenniman first reported a position in TECH in Q1 2025 and held it in 2 quarters. The position peaked at $253K in Q1 2025. 576 funds tracked by Wall St. Rank hold TECH as of Q3 2025.

  • Fulton Breakefield Broenniman reported no remaining Bio-Techne position as of Q3 2025 after selling out during the quarter.
  • Fulton Breakefield Broenniman sold 4,435 Bio-Techne shares in Q3 2025, an estimated $228K.
  • Fulton Breakefield Broenniman first reported a position in Bio-Techne in Q1 2025 and held it in 2 quarters.
  • Fulton Breakefield Broenniman's Bio-Techne position peaked at $253K in Q1 2025.
  • 576 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2025.

Based on Fulton Breakefield Broenniman's 13F filing for Q3 2025, filed 16 Oct 2025.